Reference
FDA is changing the therapeutic equivalence rating for Accord Healthcare Inc.'s generics of Prograf (tacrolimus) oral capsules Internet Document : 18 Sep 2023. Available from: URL: https://www.fda.gov/drugs/drug-safety-and-availability/fda-changing-therapeutic-equivalence-rating-accord-healthcare-incs-generics-prograf-tacrolimus-oral
Rights and permissions
About this article
Cite this article
FDA changes therapeutic equivalence rating for Accord Healthcare's tacrolimus. Reactions Weekly 1975, 5 (2023). https://doi.org/10.1007/s40278-023-46360-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-46360-5